![Massive single-cell atlas across human tissues highlights cell types where disease genes are active | Broad Institute Massive single-cell atlas across human tissues highlights cell types where disease genes are active | Broad Institute](https://www.broadinstitute.org/files/news/images/2022/HCA_GTEx_2022_main.jpg)
Massive single-cell atlas across human tissues highlights cell types where disease genes are active | Broad Institute
![Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria | Scientific Reports Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-06376-4/MediaObjects/41598_2022_6376_Fig1_HTML.png)
Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria | Scientific Reports
![Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing | npj Precision Oncology Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-023-00429-1/MediaObjects/41698_2023_429_Fig1_HTML.png)
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing | npj Precision Oncology
![Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications. - Abstract - Europe PMC Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6528487/bin/PO.18.00100t1.jpg)
Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications. - Abstract - Europe PMC
![When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine](https://www.thelancet.com/cms/asset/8f79473d-e135-42c7-8e48-de1763def587/gr1.jpg)